Additional European Equity News

Adyen (ADYEN NA) - FY21 (EUR): Revenue 1.0bln (prev. 684mln Y/Y). EBITDA 630mln (prev 403mln). (Newswires)

Aegon (AGN NA) - H2 2021 (EUR): Net 526mln (271mln Y/Y). ROW 9.0% (prev. 10.3% Y/Y). Gross Deposits 69bln (prev. 44.2bln Y/Y). (Newswires)

Anglo American (AAL LN) – Started-up the Aquila metallurgical coal mine. (Newswires)

Barratt Developments (BDEV LN) - H1 2022 (GBP): Revenue 432.6mln (prev. 430.25mln Y/Y). Revenue 2.25bln (prev. 2.49bln Y/Y). ROCE 26.8% (prev. 17.7% Y/Y). (Newswires)

Darktrace (DARK LN) - Mandiant (MNDT) pared back after hours gains after weaker earnings for Q4 and a soft Q1 outlook; gains were supported by earlier reports that Microsoft (MSFT) was in talks to acquire Mandiant. (Bloomberg)

GlaxoSmithKline (GSK LN) – FY21 (GBP): Revenue 34.1bln (exp. 33.8bln), dividend 0.80 (exp. 0.785), adj. EPS 1.132 (exp. 1.091). On track to demerge a new consumer healthcare business mid-2022; new GSK Biopharma Business is expected to deliver growth in FY22 sales of 5-7%. FY22 guidance excludes and contribution from COVID solutions, for FY22 based on binding agreements expect COVID solutions will contribute a similar sales level as in FY21. Shingrix: expect strong double-digit growth and record sales in 2022. (Newswires)

Lundbeck (LUNE SS) - FY21 (DKK): Core EBIT 3.52bln (prev. 4.44bln Y/Y). Core Revenue 16.3bln (prev. 17.7bln Y/Y). Proposes a new share structure with A & B shares, to increase financial capacity to fund future growth opportunities. Will not impact the dividend policy or distribution of voting rights. (Newswires)

Maersk (MAERSKB DC) - Q4 2021 (USD): Revenue 18.51bln (exp. 17.89bln). Underlying EBITDA 7.99bln (exp. 8bln). Sees 2022 underlying EBITDA around 24bln (exp. 28bln). Sees 2022 global container trade +2% to +4%. Maersk acquires Pilot Freight Services for USD 1.68bln. (Newswires)

Pandora (PNDORA DC) – Q4 2021 (DKK): Revenue 9.01bln (prelim 9.0bln). EBIT 2.68bln (prelim 2.7bln). Co. has launched a DKK 3.3bln share buyback programme. Co. assumes general US jewellery market to contract 10-20% this year. Says the performance in China was unsatisfactory and negatively impacted by COVID. Key sustainability target is to only use lab-grown diamonds going forward. (Newswires)

QIAGEN (QIA GY) - Shares rallied in US after hours trading as results topped expectations and its outlook was decent. Q4 EPS 0.74 (exp. 0.53), and Q4 revenue USD 582mln (exp. 461.3mln). Expects a significant decline in COVID-19 product sales this year, but CEO said results showed QIAGEN was not COVID dependent, has portfolio to drive future growth. Sees double-digit CER growth in its non-COVID portfolio, sees FY22 net sales of USD 2.07bln (exp. 2.05bln), and EPS of at least 2.05 (exp. 2.03). (QGEN)

Roche (ROG SW) - South Africa's Competition Commission has filed a referral with the tribunal for the prosecution of Roche over alleged excessive pricing of a breast cancer drug, Trastuzumab, asking the tribunal to impose the maximum penalty. (Newswires)

Saipem (SPM IM) - Two separate internal audits are now underway to determine how the Co. ended up posting a FY21 loss in excess of a third of the overall equity, according to La Republicca. (Newswires)

Smurfit Kappa (SKG LN) - FY21 (EUR): EBITDA 1.7bln (exp. 1.67bln). Costs regarding energy recovered by fibre and other raw materials remain elevated. Trading is strong. Final dividend increased by 10%. (Newswires)

Stellantis (STLA IM/FP) - Italy's Industry Minister will be speaking with auto representatives on possible industry incentives. (Newswires)

Voestalpine (VOE AT) - 9M 2021 (EUR): Revenue 10.9bln (prev. 7.97bln). EBITDA 1.55bln (prev. 682mln). Net 697.6mln (prev. -159mln). Co. narrowed FY22 EBITDA guidance. (Newswires)

Banco Sabadell (SAB SM) upgraded to Market Perform from Underperform at Keefe Bruyette

BHP (BHP LN) downgraded to Underperform from Neutral at Exane BNP

Randstad (RAND NA) upgraded to Outperform from Neutral at Oddo Securities

09 Feb 2022 - 07:32- Equities- Source: Newsquawk